MedPath

Elinest

ELINEST™ (Norgestrel and Ethinyl Estradiol Tablets, USP)Rx only

Approved
Approval ID

aa7f4a83-71cf-4306-b0a1-01784f67bae2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2023

Manufacturers
FDA

Northstar Rx LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norgestrel and Ethinyl Estradiol

PRODUCT DETAILS

NDC Product Code16714-365
Application NumberANDA091105
Marketing CategoryC73584
Route of AdministrationN/A
Effective DateJanuary 31, 2023
Generic NameNorgestrel and Ethinyl Estradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Elinest - FDA Drug Approval Details